Comprehensive Care for HCM
Hypertrophic cardiomyopathy (HCM) is a genetic condition in which the heart muscle becomes abnormally thickened, potentially obstructing blood flow and increasing the risk of arrhythmias. Our cardiology team provides comprehensive evaluation, risk stratification, and individualized management for patients with HCM — including family screening recommendations, activity guidance, and medication optimization.
If you or a family member has been diagnosed with HCM, specialized cardiology care is essential. Schedule an evaluation with a cardiologist trained in managing structural heart muscle disorders.
- Expert risk stratification to assess sudden cardiac death risk and guide prevention strategies
- Individualized management including medication optimization, activity guidance, and family screening
- Ongoing monitoring with advanced imaging to track disease progression
Book Appointment
Expert Consultation
Advanced Diagnosis
Key Benefits of Hypertrophic Cardiomyopathy (HCM)
HCM is the most common genetic heart condition and a leading cause of sudden cardiac death in young athletes and adults. Proper management requires expertise in risk stratification — determining which patients are at higher risk and may benefit from preventive interventions such as implantable defibrillators. Equally important is identifying family members who may carry the gene and need screening.
Frequently asked question
Yes. HCM is typically caused by genetic mutations that are inherited in an autosomal dominant pattern, meaning each child of an affected parent has a 50% chance of inheriting the condition. Family screening with echocardiography and genetic counseling is recommended.
Exercise recommendations depend on the severity of your condition and risk profile. Dr. Saad will provide individualized activity guidance based on your specific findings. Many patients with HCM can participate in moderate exercise safely.
Treatment options include medications to reduce symptoms and obstruction, lifestyle modifications, and in some cases interventional or surgical procedures. Newer targeted medications for obstructive HCM have significantly expanded treatment options in recent years.